Diane L. Tribble
About
Diane L. Tribble is a scholar working on Surgery, Biochemistry and Endocrinology, Diabetes and Metabolism.
According to data from OpenAlex, Diane L. Tribble has authored 65 papers receiving a total of 7.2k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Surgery, 22 papers in Biochemistry and 15 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Diane L. Tribble's work include Lipoproteins and Cardiovascular Health (29 papers), Antioxidant Activity and Oxidative Stress (22 papers) and Cancer, Lipids, and Metabolism (14 papers). Diane L. Tribble is often cited by papers focused on Lipoproteins and Cardiovascular Health (29 papers), Antioxidant Activity and Oxidative Stress (22 papers) and Cancer, Lipids, and Metabolism (14 papers). Diane L. Tribble collaborates with scholars based in United States, Netherlands and Norway. Diane L. Tribble's co-authors include Ronald M. Krauss, Alan Chait, Dean P. Jones, Ronald Brazg, Peter D. Wood, Judith Wylie‐Rosett, Barbara V. Howard, Alice H. Lichtenstein, Terry L. Bazzarre and John W. Suttie and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Circulation.
In The Last Decade
Diane L. Tribble
63 papers receiving 6.8k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Diane L. Tribble United States | 34 | 2.9k | 2.0k | 1.3k | 1.3k | 1.1k | 65 | 7.2k | ||
| Rajasekhar Ramakrishnan United States | 48 | 2.0k 0.7× | 1.5k 0.7× | 1.5k 1.1× | 1.6k 1.3× | 593 0.6× | 118 | 6.4k | ||
| Matti J. Tikkanen Finland | 48 | 2.8k 0.9× | 3.0k 1.5× | 800 0.6× | 1.3k 1.0× | 558 0.5× | 226 | 8.1k | ||
| Hiroshige Itakura Japan | 45 | 3.4k 1.2× | 2.4k 1.2× | 2.7k 2.0× | 1.7k 1.3× | 618 0.6× | 168 | 9.5k | ||
| S M Grundy United States | 41 | 2.6k 0.9× | 2.2k 1.1× | 1.1k 0.8× | 899 0.7× | 525 0.5× | 73 | 6.0k | ||
| Patrick Couture Canada | 52 | 3.0k 1.0× | 2.7k 1.3× | 1.9k 1.4× | 1.5k 1.2× | 1.5k 1.4× | 276 | 8.6k | ||
| Helena Gylling Finland | 50 | 4.7k 1.6× | 1.8k 0.9× | 1.7k 1.3× | 2.1k 1.6× | 653 0.6× | 225 | 8.0k | ||
| Shinichi Oikawa Japan | 49 | 3.2k 1.1× | 3.0k 1.5× | 2.9k 2.2× | 1.5k 1.1× | 574 0.5× | 211 | 9.3k | ||
| Steen Stender Denmark | 50 | 1.9k 0.7× | 1.8k 0.9× | 1.6k 1.2× | 961 0.7× | 1.9k 1.7× | 207 | 8.6k | ||
| Jeffrey S. Cohn Canada | 53 | 3.0k 1.0× | 3.9k 2.0× | 1.3k 1.0× | 2.3k 1.8× | 649 0.6× | 113 | 9.6k | ||
| G. Russell Warnick United States | 40 | 3.8k 1.3× | 4.8k 2.4× | 1.0k 0.8× | 1.2k 0.9× | 1.0k 1.0× | 88 | 9.5k |
Countries citing papers authored by Diane L. Tribble
Since
Specialization
Citations
This map shows the geographic impact of Diane L. Tribble's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Diane L. Tribble with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Diane L. Tribble more than expected).
Fields of papers citing papers by Diane L. Tribble
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Diane L. Tribble. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Diane L. Tribble. The network helps show where Diane L. Tribble may publish in the future.
Co-authorship network of co-authors of Diane L. Tribble
This figure shows the co-authorship network connecting the top 25 collaborators of Diane L. Tribble. A scholar is included among the top collaborators of Diane L. Tribble based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Diane L. Tribble. Diane L. Tribble is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Stein, Evan A., Robert Dufour, Claude Gagné, et al.. (2012). Apolipoprotein B Synthesis Inhibition With Mipomersen in Heterozygous Familial Hypercholesterolemia. Circulation. 126(19). 2283–2292.
2.
Dansky, Hayes M., Daniel M. Bloomfield, Patrice H. Gibbons, et al.. (2011). Efficacy and safety after cessation of treatment with the cholesteryl ester transfer protein inhibitor anacetrapib (MK-0859) in patients with primary hypercholesterolemia or mixed hyperlipidemia. American Heart Journal. 162(4). 708–716.
3.
Akdim, Fatima, Erik S.G. Stroes, Eric J.G. Sijbrands, et al.. (2010). Efficacy and Safety of Mipomersen, an Antisense Inhibitor of Apolipoprotein B, in Hypercholesterolemic Subjects Receiving Stable Statin Therapy. Journal of the American College of Cardiology. 55(15). 1611–1618.
4.
Cromwell, William C., Dirk Blom, A. David Marais, et al.. (2010). P431 MIPOMERSEN, AN apo B SYNTHESIS INHIBITOR, PREFERENTIALLY REDUCES SMALL LDL PARTICLE NUMBER AND INCREASES LDL PARTICLE SIZE IN HoFH PATIENTS. Atherosclerosis Supplements. 11(2). 107–108.
5.
Cromwell, William C., Robert Dufour, Claude Gagné, et al.. (2010). Abstract 19931: Mipomersen, An Apolipoprotein B Synthesis Inhibitor, Reduces Small LDL Particle Number and Increases LDL Particle Size in Patients with Heterozygous Familial Hypercholestrolemia and Coronary Artery Disease. Circulation. 122(21). c4305–c4305.
6.
Cromwell, William C., Raúl D. Santos, Dirk Blom, et al.. (2010). Mipomersen, a First-in-Class Apolipoprotein B Synthesis Inhibitor, Lowers Lipoprotein (a) in Patients with Homozygous Familial Hypercholesterolemia. Journal of clinical lipidology. 4(3). 221–221.
7.
Visser, Maartje E., Fatima Akdim, Diane L. Tribble, et al.. (2009). Effect of apolipoprotein-B synthesis inhibition on liver triglyceride content in patients with familial hypercholesterolemia. Journal of Lipid Research. 51(5). 1057–1062.
8.
Yu, Rosie Z., et al.. (2008). Lack of Pharmacokinetic Interaction of Mipomersen Sodium (ISIS 301012), a 2′-O-Methoxyethyl Modified Antisense Oligonucleotide Targeting Apolipoprotein B-100 Messenger RNA, with Simvastatin and Ezetimibe. Clinical Pharmacokinetics. 48(1). 39–50.
9.
Yu, Rosie Z., Kristina M. Lemonidis, Mark J. Graham, et al.. (2008). Cross-species comparison of in vivo PK/PD relationships for second-generation antisense oligonucleotides targeting apolipoprotein B-100. Biochemical Pharmacology. 77(5). 910–919.
10.
Feldman, Theodore, Leiv Ose, Arvind Shah, et al.. (2007). Efficacy and Safety of Ezetimibe/Simvastatin Versus Simvastatin Monotherapy in Hypercholesterolemic Patients with Metabolic Syndrome. Metabolic Syndrome and Related Disorders. 5(1). 13–21.
11.
Assmann, Gerd, Frank Kannenberg, Wayne Weng, et al.. (2004). 1008-183 Effects of ezetimibe, simvastatin, and ezetimibe-simvastatin on noncholesterol sterol. Journal of the American College of Cardiology. 43(5). A445–A446.
12.
Bays, Harold, Leiv Ose, Neil J. Fraser, et al.. (2004). 1084-179 Ezetimibe/Simvastatin therapy is more effective than simvastatin alone at reducing remnant-like particle cholesterol. Journal of the American College of Cardiology. 43(5). A481–A481.
13.
Tribble, Diane L.. (2001). Antioxidants and atherosclerotic cardiovascular disease: unresolved issues. Coronary Artery Disease. 12(7). 541–546.
14.
Tribble, Diane L., et al.. (2001). Enhanced oxidative susceptibility and reduced antioxidant content of metabolic precursors of small, dense low-density lipoproteins. The American Journal of Medicine. 110(2). 103–110.
15.
Gardner, Christopher D., Diane L. Tribble, Deborah Rohm Young, David K. Ahn, & Stephen P. Fortmann. (2000). Population Frequency Distributions of HDL, HDL2, and HDL3 Cholesterol and Apolipoproteins A-I and B in Healthy Men and Women and Associations with Age, Gender, Hormonal Status, and Sex Hormone Use: The Stanford Five City Project. Preventive Medicine. 31(4). 335–345.
16.
Gardner, Christopher D., Diane L. Tribble, Deborah Rohm Young, David K. Ahn, & Stephen P. Fortmann. (2000). Associations of HDL, HDL2, and HDL3 Cholesterol and Apolipoproteins A-I and B with Lifestyle Factors in Healthy Women and Men: The Stanford Five City Project. Preventive Medicine. 31(4). 346–356.
17.
Berg, Jeroen J.M. van den, et al.. (1995). Reinvestigation of the antioxidant properties of conjugated linoleic acid. Lipids. 30(7). 599–605.
18.
Tribble, Diane L., Maarten G. Lansberg, Ronald M. Krauss, Frans A. Kuypers, & Jeroen J.M. van den Berg. (1993). Compartmentalization of oxidative injury in low density lipoproteins (LDL): Evidence for two kinetic pools corresponding to the LDL surface monolayer and hydrophobic core. Free Radical Biology and Medicine. 15(5). 540–540.
19.
Tribble, Diane L. & Dean P. Jones. (1990). Oxygen dependence of oxidative stress. Biochemical Pharmacology. 39(4). 729–736.
20.
Tribble, Diane L., Tak Yee Aw, & Dean P. Jones. (1987). The pathophysiological significance of lipid peroxidation in oxidative cell injury. Hepatology. 7(2). 377–386.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Rajasekhar Ramakrishnan Breakdown of academic impact, for papers by Matti J. Tikkanen Breakdown of academic impact, for papers by Hiroshige Itakura Breakdown of academic impact, for papers by S M Grundy Breakdown of academic impact, for papers by Patrick Couture Breakdown of academic impact, for papers by Helena Gylling Breakdown of academic impact, for papers by Shinichi Oikawa Breakdown of academic impact, for papers by Steen Stender Breakdown of academic impact, for papers by Jeffrey S. Cohn Breakdown of academic impact, for papers by G. Russell Warnick